Læknablaðið - 15.11.2007, Page 17

FRÆÐIGREIN
HJARTALÍNUR
A R
77
3. Lorell BH, Carabello BA. Left ventricular hypertrophy.
Pathogenesis, detection and prognosis. Circulation 2000; 102:
470.
4. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH.
Relation of left ventricular mass and geometry to morbidity
and mortality in uncomplicated essential hypertension. Ann
Intem Med 1991; 114: 345-52.
5. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP.
Prognostic implications of echocardiographically determined
left ventricular mass in the Framingham Heart Study. N Engl
J Med 1990; 322:1561-6.
6. Verdecchia P, Carini G, Circo A, Dovellini E. Left ventricular
mass and cardiovascular morbidity in essential hypertension:
the MAVI study. J Am Coll Cardiol 2001; 38:1829.
7. Siscovick DS, Raghunathan TE, Rautaharju P, Psaty BM,
Cobb LA, Wagner EH. Clinically silent electrocardiographic
abnormalities and risk of primary cardiac arrest among
hypertensive patients. Circulation 1996; 94:1329-33.
8. Dunn FG, Pringle SD. Sudden cardiac death, ventricular
arrhythmias and hypertensive left ventricular hypertrophy. J
Hypertens 1993; 11:1003.
9. Liao Y, Cooper RS, Durazo-Arvizu R, Mensah GA, Ghali
JK. Prediction of mortality risk by different methods of
indexation for left ventricular mass. J Am Coll Cardiol 1997;
29: 641-7.
10. Bella JN, Wachtell K, Boman K, Palmieri V, Papademetriou
V, Gerdts E, et al. Relation of left ventricular geometry and
function to aortic root dilatation in patients with systemic
hypertension and left ventricular hypertrophy (the LIFE
study). Am J Cardiol 2002; 89: 337-41.
11. Verdecchia P, Porcellati C, Reboldi G, Gattobigio R, Borgioni
C, Pearson TA, et al. Left ventricular hypertrophy as an
independent predictor of acute cerebrovascular events in
essential hypertension. Circulation 2001; 104: 2039-44.
12. Drazner MH, Rame JE, Marino EK, Gottdiener JS, Kitzman
DW, Gardin JM, et al. Increased left ventricular mass is a risk
factor for the development of a depressed left ventricular
ejection fraction within five years: the Cardiovascular Health
Study. J Am Coll Cardiol 2004; 43: 2207-15.
13. Devereux RB, Casale PN, Wallerson DC, Kligfield P,
Hammond IW, Leibson PR, et al. Cost-effectiveness
of echocardiography for detection of left ventricular
hypertrophy in patients with systemic hypertension.
Hypertension 1987; 9(suppl II):II-69-ll-76.
14. Sokolow M, Lyon TP. The ventricular complex in left
ventricular hypertrophy as obtained by unipolar precordial
and limb leads. Am Heart J 1949; 37:161-86.
15. Romhilt DW, Estes EH. Point score system for the ECG
diagnosis of left ventricular hypertrophy. Am Heart J 1968;
75: 752-8.
16. Okin PM, Devereux RB, Jem S, Kjeldsen SE, Julius S,
Nieminen MS, et al. LIFE Study Investigators. Regression
of electrocardiographic left ventricular hypertrophy during
antihypertensive treatment and the prediction of major
cardiovascular events. JAMA 2004; 292: 2343-9.
17. Þráinsdóttir IS, Harðarson T, Þorgeirsson G, Sigvaldason
H, Sigfússon N. Survival and trends of occurrence of left
ventricular hypertrophy, gender differences, 1967-92: The
Reykjavik Study. J Intem Med 2003; 253: 418-24.
18. Sigurðsson E, Þorgeirsson G, Sigvaldason H, Sigfússon N.
Prevalence of coronary heart disease in Icelandic men 1968-
1986. The Reykjavik Study. Eur Heart J 1993; 14: 584-91.
19. Jónsdóttir LS, Sigf ússon N, Sigvaldason H, Þorgeirsson G.
Incidence and prevalence of recognised and unrecognised
myocardial infarction in women. The Reykjavik Study. Eur
Heart J 1998; 19:1011-8.
20. Efron B, Tibshirani RJ. An Introduction to the Bootstrap.
Chapman and Hall / CRC 1998.
21. Levy D, Labib SB, Anderson KM, Christiansen JC,
Kannel WB, Castelli WP. Determinants of sensitivity and
specificity of electrocardiographic criteria for left ventricular
hypertophy. Circulation 1990; 81: 815-20.
22. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen
JC, Castelli WP. Echocardiographically detected left
ventricular hypertrophy: Prevalence and risk factors. Ann
Intem Med 1988; 108: 7-13.
23. Rautaharju PM, LaCroix AZ, Savage DD, Haynes SG,
Madans JH, Wolf HK, et al. Electrocardiographic estimate of
left ventricular mass versus radiographic cardiac size and the
risk of cardiovascular disease mortality in the epidemiologic
follow-up study of the First National Health and Nutrition
Examination Survey. Am J Cardiol 1988; 62: 59-66.
24. Larsen CT, Dahlin J, Blackbum H, Scharling H,
Appleyard M, Sigurd B, et al. Prevalence and prognosis
of electrocardiographic left ventricular hypertrophy, ST
segment depression and negative T-wave; the Copenhagen
City Heart Study. Eur Heart J 2002; 23: 315 - 24.
25. Hsieh BP, Pham MX, Froelicher VF. Prognostic value of
electrocardiographic criteria for left ventricular hypertrophy.
Am Heart J 2005; 150:161-7.
26. Casale PN, Deveraux RB, Kligfield P, Eisenberg RR, Miller
DH, Chaudhary BS, et al. Electrocardiographic detection of
left ventricular hypertrophy: Development and prospective
validation of improved criteria. J Am Coll Cardiol 1985; 6:
572-80.
27. Casale PN, Deveraux RB, Alonso DR, Campo E, Kligfield P.
Improved sex-specific criteria of left ventricular hypertrophy
for clinical and computer interpretation of electrocardiograms:
Validation with autopsy findings. Circulation 1987; 75: 565-
72.
28. Levy D, Bailey JJ, Garrison RJ, Horton MR, Balkus SM, Lyons
D, et al. Electrocardiographic changes with advancing age. J
Electrocardiol 1987; 20 (suppl): 44-7.
29. LaMonte CS, Freiman AH. The electrocardiogram after
mastectomy. Circulation 1965; 32: 746-54.
LÆKNAblaðið 2007/93 749